EquityZen Growth Technology Fund LLC - Series 2200
Raised
$160K
Investors
13
Min Invest
$10,000
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 2200 is a Delaware pooled investment fund vehicle filed by EquityZen Advisors and Philip Haslett on 2025-12-30. The fund raised $160K from 13 investors with a $10K minimum investment, relying on Rule 506(b) and Section 3(c)(1) exemptions. It is part of the EquityZen platform, which operates 1,889 related EDGAR entities focused on pre-IPO secondary markets.
This pre-IPO fund uses the standard 506(b)/3(c)(1) exemption structure typical of private placement vehicles targeting accredited investors. The $10K minimum investment and $160K total raise reflect a small series vehicle consistent with EquityZen's platform model of creating discrete SPVs for individual pre-IPO company exposures, with investor economics aligning to narrow deal-by-deal access rather than broad fund commitments.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
